| Literature DB >> 35343419 |
Nambram Somendro Singh1,2, Neelja Singhal2, Manish Kumar2, Jugsharan Singh Virdi1.
Abstract
Entities:
Year: 2022 PMID: 35343419 PMCID: PMC9044524 DOI: 10.1017/S095026882200053X
Source DB: PubMed Journal: Epidemiol Infect ISSN: 0950-2688 Impact factor: 4.434
Details of primers and PCR conditions used for analyses of plasmid-associated quinolone and aminoglycoside resistance genes, and genetic environment of qnrS in E. coli isolated from a major urban river of India
| Primers | Nucleotide sequence | Target genes | Amplicon size (bp) | Annealing temperature (°C) | References |
|---|---|---|---|---|---|
| RMTA-F | 5′-CTAGCGTCCATCCTTTCCTC-3′ | 653 | 57 | [ | |
| RMTB-F | 5′-GCTTTCTGCGGGCGATGTAA-3′ | 173 | 60 | [ | |
| RMTC-F | 5′-CGAAGAAGTAACAGCCAAAG-3′ | 711 | 55 | [ | |
| ARMA-F | 5′-ATTCTGCCTATCCTAATTGG-3′ | 315 | 46 | [ | |
| str-F | 5′-TATCTGCGATTGGACCCTCTG-3′ | 538 | 62 | [ | |
| aacC2-F | 5′-TAGAGGAGTATCGCGATGC-3′ | 861 | 55 | [ | |
| AphA1-F | 5′-ATGGGCTCGCGATAATGTC-3′ | 600 | 55 | [ | |
| QA-F | 5′-TCGCCGCTGCCGCTTTTAT-3′ | 517 | 60 | [ | |
| QB-F | 5′-AACCTGAAAGATGCCATT-3′ | 405 | 50 | [ | |
| QC-F | 5′-GGGTTGTACATTTATTGAATC-3′ | 447 | 50 | [ | |
| QD-F | 5′-CGAGATCAATTTACGGGGAATA-3′ | 582 | 57 | [ | |
| QS-F | 5′-GACGTGCTAACTTGCGTGAT-3′ | 456 | 55 | [ | |
| ACC-F | 5′TTGCGATGCTCTATGAGTGGCTA-3′ | 482 | 60 | [ | |
| QEP-F | 5′-CTGCAGGTACTGCGTCATG-3′ | 403 | 55 | [ | |
| XA-F | 5′-GACAGCGTCGCACAGAATG-3′ | 339 | 62 | [ | |
| XB-F | 5′-CGAAGAAAGACCTCCCTACCC-3′ | 240 | 62 | [ | |
| Pre-qnrs1-F | 5′-CTGATAACACTTCAACCATC-3′ | IS | 1113 | 50 | [ |
| IS26-F | 5′GTACGGCCCACAGAATGATGTC-3′ | IS | 2381 | 50 | [ |
| IS26-F | 5′GTACGGCCCACAGAATGATGTC-3′ | IS | 1100 | 45 | [ |
Resistance phenotypes and plasmid-associated genes encoding flouro(quinolone) and aminoglycoside resistance in E. coli strains isolated from a major urban river of India
| Strain designation | Phylogroup | Antibiotic resistance | Resistance gene(s) | Genetic environment of |
|---|---|---|---|---|
| IPH | A | – | – | – |
| IPS | A | – | – | – |
| IS5 | A | – | – | – |
| IS57 | A | – | – | – |
| IS58 | A | STM | – | |
| IS76 | A | – | – | – |
| IPI | A | – | – | – |
| IP1 | A | – | – | – |
| KK36 | A | – | IS | |
| KK30 | A | – | IS | |
| NG28 | A | – | – | – |
| NG9 | A | – | – | – |
| PA18 | A | – | – | – |
| IP11 | A | – | – | – |
| IP18 | A | – | IS | |
| IS40 | A | – | – | – |
| MKNJ | A | – | IS | |
| WB23 | A | – | IS | |
| WB31 | A | – | IS | |
| DND14 | A | – | – | – |
| KP5S | A | – | – | – |
| KP21 | A | – | IS | |
| IST | A | KAN | IS | |
| NG3 | A | – | – | – |
| PA21 | A | – | – | – |
| WB28 | A | GEN | – | |
| IPG | A | – | – | – |
| IS54 | A | – | – | – |
| IP24 | B1 | NAL, CIP, OFX | IS | |
| ISD | B1 | – | IS | |
| KK32 | B1 | STM | – | |
| NG29 | B1 | – | – | – |
| PA4 | B1 | – | – | – |
| MKNE | B1 | – | – | – |
| SVI | B1 | – | – | – |
| DND6 | B1 | – | – | – |
| DND1 | B1 | – | – | – |
| WB4 | B1 | – | – | – |
| NG32 | B1 | – | – | – |
| IP5N | B1 | – | – | – |
| PA32 | B1 | – | – | – |
| KK46 | B1 | – | – | – |
| WB14 | B1 | – | – | – |
| ISI | B2 | – | – | – |
| KP24 | B2 | STM | – | |
| MKNG | B2 | – | – | – |
| IP9 | D | – | – | – |
| IPE | D | NAL, CIP, OFX, KAN | – | |
| ISE | D | STM | – | |
| KK16 | D | STM | IS | |
| KK45 | D | KAN, GEN | – | |
| NG37 | D | STM, KAN | – | |
| PA6 | D | – | – | – |
| KP31 | D | – | – | – |
| MKND | D | KAN | – | |
| PA24 | D | – | – | – |
| WB6 | D | STM | IS | |
| KK38 | D | STM | – | |
| KK31 | D | – | IS | |
| KKA | D | STM | IS | |
| PA12 | D | STM | IS |
STM, streptomycin; GEN, gentamicin; KAN, kanamycin; NAL, nalidixic acid; CIP, ciprofloxacin; OFX, ofloxacin.